| Literature DB >> 27312725 |
Peter Tollman1, Valery Panier1, Diana Dosik1, Paul Biondi2, Francis Cuss2.
Abstract
While the pharmaceutical industry overall has faced huge challenges in drug R&D in recent years, some major companies have consistently been much more productive than average. Here, we highlight 'organizational effectiveness' as a key factor underlying this superior performance and explain how it can be enhanced.Entities:
Mesh：
Year: 2016 PMID： 27312725 DOI： 10.1038/nrd.2016.91
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694